Newsroom

The journal Frontiers in Medicine, Nuclear Medicine section, publishes a case report from Carilion Clinic highlighting the impact of an FDG PET/CT radiotracer injection infiltration on patient management.

“Dose extravasation in PET/CT has the potential of reducing image quality and affecting accurate SUV quantification. These case studies demonstrate how the ability to accurately identify, measure and implement a process improvement program to reduce dose extravasations can ultimately have a positive impact on patient outcomes in PET/CT.” Full Text

“Analysis of time activity curves from both detectors indicate that use of these detectors can provide specific information about a particular radioactive sphere infusion procedure. Data can be used to optimize techniques for a given Y90 therapy device or used to train radiology residents on proper technique. This method can also provide near real-time confirmation of a successful complete delivery of the desired patient dose which may also maximize therapy efficacy and improve patient outcomes.”
Full Text

“A combination of deep learning techniques and TACs from external sensors is a novel approach which can play a significant role in classifying infiltrated injections. With the date constraint factor, the highest accuracy achieved was in the range of 70%. However, the system could identify the good injections with 85% accuracy and with 90% accuracy when using only the original data. Future work aims at training the network with sufficient date with improved mode to achieve better accuracy.” Full Text

“Since infiltrations can resolve during uptake and as the standard imaging FOV does not always capture the injection site, many infiltrations may go undetected. Infiltrations result in underestimated SUVs that can impact patient care emphasizing that it is important to monitor injection quality. Thus, identifying contributing factors associated with infiltrations may help stimulate quality improvements, reduce infiltration rates, and potentially improve patient care.”
Full Text

Lucerno Dynamics second patent issued by USPTO.

“Even when the injection site was out of the field of view, the time–activity curves could still detect and characterize infiltration. Our initial experience showed that the quality assurance information obtained from the device helped reduce the rate and severity of infiltration.” Full Text

Two presentations at the SNMMI annual meeting discuss results from using the Lucerno system at Saint Louis University, with abstracts published on
Prolonged Venous Stasis and
a Pilot Quality Improvement Study .

The Triangle Business Journal publishes an interview with Ron Lattanze (subscription required).

The SNMMI SmartBrief publishes a synopsis of the Lara^®-QI study in their daily update, directing readers to the WRAL Techwire report for more information.

The Triangle Business Journal reports that the Lara^®-QI Study is up and running, with the first site at Roanoke, Virginia-based Carilion Clinic.

Lucerno Dynamics has initiated a quality improvement study on the radiotracer injection process for patients undergoing PET/CT imaging. Press Release